Skip to main content

pmIL-6 mut AP-1+C/EBP
(Plasmid #61292)

Full plasmid sequence is not available for this item.

Loading...

Ordering

This material is available to academics and nonprofits only.
Item Catalog # Description Quantity Price (USD)
Plasmid 61292 Standard format: Plasmid sent in bacteria as agar stab 1 $94
DNA 61292-D50 50 μg of DNA in Tris buffer $495
DNA 61292-D100 100 μg of DNA in Tris buffer $585

Backbone

  • Vector backbone
    pGL2 basic
  • Backbone manufacturer
    Promega
  • Total vector size (bp) 6877
  • Modifications to backbone
    pGL2-Basic vector was digested with BglII and HindIII. The PCR product generated from primers mIL6BAM and mIL6HIND using CH12.LX genomic DNA as template was digested with BamHI and HindIII, and ligated into the digested pGL2-Basic vector which destroyed the 5' BglII/BamHI cloning site
  • Vector type
    Mammalian Expression, Luciferase

Growth in Bacteria

  • Bacterial Resistance(s)
    Ampicillin, 100 μg/mL
  • Growth Temperature
    37°C
  • Growth Strain(s)
    DH5alpha
  • Copy number
    Unknown

Gene/Insert

  • Gene/Insert name
    IL-6 promoter
  • Species
    M. musculus (mouse)
  • Mutation
    Mutated both AP-1 binding site from TGAGTCT to TGCAGCT and C/EBP binding site from ACATTGTGCAATCT to ACAGATATCAATCT
  • Entrez Gene
    Il6 (a.k.a. Il-6)
  • Promoter IL-6 promoter with mutant AP-1 and C/EBP binding sites

Cloning Information

  • Cloning method Restriction Enzyme
  • 5′ cloning site BglII (destroyed during cloning)
  • 3′ cloning site HindIII (not destroyed)
  • 5′ sequencing primer EBV-rev
  • 3′ sequencing primer LucNRev
  • (Common Sequencing Primers)

Resource Information

  • A portion of this plasmid was derived from a plasmid made by
    See publication for cloning details.

Terms and Licenses

Trademarks:

  • Zeocin® is an InvivoGen trademark.

Depositor Comments

Contains point mutations in both AP-1 and C/EBP binding sites. See Table 1 of associated publication for more details.

Full sequence and map is available for wild-type vector pmIL-6 FL (Plasmid #61290)

Purpose

Ready-to-use, high-purity DNA prep. DNA aliquots are suitable for use in mammalian cell transfections and other molecular biology applications.

Delivery

  • Amount 50 μg
  • Concentration 1 μg/μL
  • Pricing $495 USD
  • Storage 4 ℃ (short-term) or -20 ℃ (long-term)

Terms and Licenses

Quality Control

Every DNA prep is verified by next-generation sequencing, confirming plasmid identity, sequence integrity, and absence of DNA contaminants. Concentration is confirmed to be within ±2.5% of the stated concentration.

Our production process has been validated to consistently yield endotoxin levels below 1.0 EU/μg. Individual lots are not tested for endotoxin.

Purpose

Ready-to-use, high-purity DNA prep. DNA aliquots are suitable for use in mammalian cell transfections and other molecular biology applications.

Delivery

  • Amount 100 μg
  • Concentration 1 μg/μL
  • Pricing $585 USD
  • Storage 4 ℃ (short-term) or -20 ℃ (long-term)

Terms and Licenses

Quality Control

Every DNA prep is verified by next-generation sequencing, confirming plasmid identity, sequence integrity, and absence of DNA contaminants. Concentration is confirmed to be within ±2.5% of the stated concentration.

Our production process has been validated to consistently yield endotoxin levels below 1.0 EU/μg. Individual lots are not tested for endotoxin.

How to cite this plasmid ( Back to top)

These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.

  • For your Materials & Methods section:

    pmIL-6 mut AP-1+C/EBP was a gift from Gail Bishop (Addgene plasmid # 61292 ; http://n2t.net/addgene:61292 ; RRID:Addgene_61292)
  • For your References section:

    CD40-mediated transcriptional regulation of the IL-6 gene in B lymphocytes: involvement of NF-kappa B, AP-1, and C/EBP. Baccam M, Woo SY, Vinson C, Bishop GA. J Immunol. 2003 Mar 15;170(6):3099-108. PubMed 12626566